INVITA HEALTH

Serial Number 88600069
Registration 7068800
700

Registration Progress

Application Filed
Aug 30, 2019
Under Examination
Mar 10, 2020
Approved for Publication
Jan 14, 2020
Published for Opposition
Jan 14, 2020
Registered
May 30, 2023

Trademark Image

INVITA HEALTH

Basic Information

Serial Number
88600069
Registration Number
7068800
Filing Date
August 30, 2019
Registration Date
May 30, 2023
Published for Opposition
January 14, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 30, 2023
Registration
Registered
Classes
042

Rights Holder

HemaTerra Technologies, LLC

16
Address
180 W Ostend St Ste 267A
Baltimore, MD 21230

Ownership History

HemaTerra Technologies, LLC

Original Applicant
16
Baltimore, MD

HemaTerra Technologies, LLC

Owner at Publication
16
Baltimore, MD

HemaTerra Technologies, LLC

Original Registrant
16
Baltimore, MD

Legal Representation

Attorney
Ned T. Himmelrich

USPTO Deadlines

Next Deadline
1417 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-05-30)
Due Date
May 30, 2029
Grace Period Ends
November 30, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description
May 30, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER
May 30, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 25, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 24, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 20, 2023 DOCK D ASSIGNED TO EXAMINER
Mar 13, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Mar 10, 2023 EISU I TEAS STATEMENT OF USE RECEIVED
Mar 10, 2023 IUAF S USE AMENDMENT FILED
Aug 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 15, 2022 EX5G S SOU EXTENSION 5 GRANTED
Aug 12, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 4, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 4, 2022 EXT5 S SOU EXTENSION 5 FILED
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 1, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 25, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 25, 2022 EXT4 S SOU EXTENSION 4 FILED
Feb 25, 2022 EX4G S SOU EXTENSION 4 GRANTED
Feb 4, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Aug 19, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 17, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 17, 2021 EXT3 S SOU EXTENSION 3 FILED
Aug 17, 2021 EX3G S SOU EXTENSION 3 GRANTED
Mar 11, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 9, 2021 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 9, 2021 EXT2 S SOU EXTENSION 2 FILED
Mar 9, 2021 EX2G S SOU EXTENSION 2 GRANTED
Sep 12, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 10, 2020 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 10, 2020 EXT1 S SOU EXTENSION 1 FILED
Sep 10, 2020 EX1G S SOU EXTENSION 1 GRANTED
Sep 9, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 9, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 9, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 9, 2020 EWAF I TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sep 9, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 9, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 10, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 14, 2020 PUBO A PUBLISHED FOR OPPOSITION
Jan 14, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 25, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 9, 2019 ALIE A ASSIGNED TO LIE
Dec 6, 2019 CNEA R EXAMINERS AMENDMENT -WRITTEN
Dec 6, 2019 GNEA F EXAMINERS AMENDMENT E-MAILED
Dec 6, 2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 6, 2019 XAEC I EXAMINER'S AMENDMENT ENTERED
Dec 6, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2019 DOCK D ASSIGNED TO EXAMINER
Sep 12, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 3, 2019 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Software as a service (SAAS) services featuring software for managing patient intake, scheduling medical services, controlling and managing patient medical information, processing and displaying medical treatment information, exchanging and managing medical treatment information, managing health care workflows, managing patient accounts, medical billing, medical vendor and manufacturer billing, tracking patient outcomes, tracking healthcare provider services, and analyzing health care business operations; SAAS services featuring software for supply chain management, vendor management, manufacturer management, storage management, inventory management, usage tracking, waste tracking, specification tracking, regulatory tracking, warranty record management, warranty claim management, and recall claim management of biologics, vaccines, pharmaceuticals, implants, tissues, medical devices, medical equipment, and medical supplies; SAAS services featuring software for managing the collection and delivery of biologics, namely, recruiting and conversion of blood donors, engaging blood donors, managing blood donation centers, providing user portal access, managing mobile blood drives, managing human resources, managing health care provider orders, planning for blood product demand, maintaining quality control of blood products and equipment, scheduling equipment calibration, providing voice over internet protocol communications, providing cloud calling communications, and providing text messaging
First Use Anywhere: 20220200
First Use in Commerce: 20220200

Additional Information

Translation
The English translation of the word "INVITA" in the mark is "INVITES".

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"HEALTH"

USPTO Documents

Loading USPTO documents...